Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
ImaginAb to Present at SNMMI 2019 Annual Meeting | ||
By: PR Newswire Association LLC. - 20 Jun 2019 | Back to overview list |
|
LOS ANGELES, June 20, 2019 /PRNewswire/ -- ImaginAb, Inc., a clinical stage immuno-oncology imaging company, today announces that it will attend and present at the upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting being held June 22-25, 2019, at the Anaheim Convention Center in Anaheim, California. ImaginAb will be presenting at the following sessions during the conference. Imaging the Immune System: CD8+ and Beyond PET scanner harmonization for multi-center clinical trials using 89Zr tracers in partnership with Clinical Trials Network (CTN) ImaginAb's lead product, CD8 tracer 89Zr-Df-IAB22M2C (89Zr), is a first in class imaging agent that visualizes the immune system using non-invasive, whole-body in vivo PET imaging of CD8 T cells. Currently, in Phase II multi-center clinical trials at world-renowned imaging and cancer centers in North America, the 89Zr ImmunoPET agent detects and visualizes CD8 T cells using ImaginAb's 'minibody' technology. This provides highly-specific, quantitative assessment of the immunological status of individual cancer lesions within a patient, potentially enabling treatment to be tailored quickly and specifically to the needs of that patient. ImaginAb, in partnership with CTN, has for the first time, implemented the harmonization of image acquisition and reconstruction parameters which are essential in undertaking multi-center 89Zr Immuno-PET imaging clinical trials. The SNMMI 2019 Annual Meeting - the premier educational, scientific, research and networking event in nuclear medicine and molecular imaging - provides physicians, technologists, pharmacists, laboratory professionals and scientists with an in-depth view of the latest research and development in the field as well as providing insights into practical applications for the clinic. ImaginAb will be based at Booth 783 in the Exhibition Hall, and in addition to presenting at the conference, will be hosting meetings with clinical investigators, pharmaceutical companies, and partner organizations. For further information or to schedule a meeting, please contact: ImaginAb Optimum Strategic Communications About ImaginAb For more information about ImaginAb's pipeline and technology, visit www.imaginab.com. About CD8 ImmunoPET View original content to download multimedia:http://www.prnewswire.com/news-releases/imaginab-to-present-at-snmmi-2019-annual-meeting-300872352.html SOURCE ImaginAb, Inc. |
||
|
||
Copyright 2019 PR Newswire Association LLC. | Back to overview list |